Elecsys® Anti-HCV II
By Roche Diagnostics · Switzerland

Key takeaways
Elecsys® Anti-HCV II is a product in the Immunoassay & Serology category, manufactured by Roche Diagnostics (Switzerland). Listed regulatory status: Availability varies by country (as reported by the manufacturer).
- Platform: Chemiluminescence Immunoassay
- Sample types: serum, plasma
- Applications: Bloodborne
- Targets: HCV and hepatitis C
Summary
Elecsys® Anti-HCV II is a nucleic acid test from Roche Diagnostics, listed for hepatitis C virus. Registration status and availability vary by market.
Classification
- Category
- Immunoassay & Serology
- Subcategory
- Infectious Disease Serology
- Product Type
- Assay Kit
- Technology
- Chemiluminescence Immunoassay
Application
- Application Area
- Bloodborne
- Target Pathogens
- HCV, hepatitis C
Workflow
- Sample Types
- Serum, Plasma
Regulatory Status
Reported from manufacturer sources and not independently verified.
Buyer Notes
Listing compiled from the manufacturer product page. Confirm registration status in the target market, sample type, and instrument compatibility before issuing an RFQ.
Related Test Guides
From the manufacturer
Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.
qualitative detection of antibodies in human serum and plasma. The electrochemiluminescence immunoassay ECLIA is intended for use on cobas e immunoassay analyzers.
Intended useElecsys Anti‑HCV II is an in vitro immunoassay for the qualitative detection of antibodies to hepatitis C virus (HCV) in human serum and plasma.
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-04
2026-10-10
availability varies
